Venu Kavarthapu

Prof. Venu Kavarthapu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
JHJoon Ha
Joon Ha
THThomas Hester
Thomas Hester
RFRobert Foley
Robert Foley
IRInes L.H. Reichert
Ines L.H. Reichert
PVPrashanth R.J. Vas
Prashanth R.J. Vas
VKVenu Kavarthapu
Venu Kavarthapu

21 December 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RARaju Ahluwalia
Raju Ahluwalia
ABAhmad Bilal
Ahmad Bilal
NPNina L Petrova
Nina L Petrova
KBKrishna Boddhu
Krishna Boddhu
Chris ManuChris Manu
Chris Manu
MEMichael Edwin Edmonds
Michael Edwin Edmonds
We describe the use of Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) in the investigation and diagnosis of Charcot neuroarthropathy (CN) in patients with a hot swollen foot but normal radiographs and clinical suspicion of CN, usually termed Stage 0. This was a retrospective cohort review of 46 diabetes patients who underwent 3 phase bone scintigraphy with “High Resolution” SPECT/CT. The imaging demonstrated that Stage 0 Charcot foot has a distinct bone pathology, which can be classified into three groups: (1) fractures on Computed Tomography (CT) with accompanying focal uptake of tracer on SPECT, (2) bony abnormalities apart from fracture on CT with focal uptake of tracer on SPECT, and (3) normal CT but focal bony uptake of tracer on SPECT. The CT component of SPECT/CT detected bony fractures in 59% of patients. Early treatment with below knee cast and follow-up for 24 months showed only 4 patients who developed Stage 1 Eichenholtz Charcot foot. Our findings support the use of 3 phase bone scintigraphy with SPECT/CT in the characterization and early diagnosis of CN. Stage 0 Charcot foot has a distinct bone pathology which requires urgent treatment to prevent progression to Stage 1 Eichenholtz Charcot foot. If SPECT/CT is unavailable, CT alone will detect bone fracture in 59% patients.

1 June 2021 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
RFRobert G. Frykberg
Robert G. Frykberg
CAChristopher Attinger
Christopher Attinger
LSLuuk Smeets
Luuk Smeets
AKArmin Koller
Armin Koller
ABArun Bal
Arun Bal
VKVenu Kavarthapu
Venu Kavarthapu

Verified
Journal Article
Open access
PDF file
VKVenu Kavarthapu
Venu Kavarthapu
JGJasdeep Giddie
Jasdeep Giddie
VKVarun Kommalapati
Varun Kommalapati
JCJoanne Casey
Joanne Casey
MBMaureen Bates
Maureen Bates
PVPrashanth Vas
Prashanth Vas
The management of diabetic foot osteomyelitis (DFO) is extremely challenging with high amputation rates reported alongside a five-year mortality risk of more than fifty percent. We describe our experience in using adjuvant antibiotic-loaded bio-composite material (Cerament) in the surgical management of DFO and infected Charcot foot reconstruction. We undertook a retrospective evaluation of 53 consecutive patients (54 feet) who underwent Gentamicin or Vancomycin-loaded Cerament application during surgery. The feet were categorised into two groups: Group 1, with infected ulcer and DFO, managed with radical debridement only (n = 17), and Group 2, requiring reconstruction surgery for infected and deformed Charcot foot. Group 2 was further subdivided into 2a, with feet previously cleared of infection and undergoing a single-stage reconstruction (n = 19), and 2b, with feet having an active infection managed with a two-stage reconstruction (n = 18). The mean age was 56 years (27–83) and 59% (31/53) were males. The mean BMI was 30.2 kg/m2 (20.8–45.5). Foot ulcers were present in 69% (37/54) feet. At a mean follow-up of 30 months (12–98), there were two patients lost to follow up and the mortality rate was 11% (n = 5). The mean duration of post-operative systemic antibiotic administration was 20 days (4–42). Thirteen out of fifteen feet (87%) in group 1 achieved complete eradication of infection. There was a 100% primary ulcer resolution, 100% limb salvage and 76% bony union rate within Group 2. However, five patients, all in group 2, required reoperations due to problems with bone union. The use of antibiotic-loaded Cerament resulted in a high proportion of patients achieving infection clearance, functional limb salvage and decrease in the duration of postoperative antibiotic therapy. Larger, preferably randomised, studies are required to further validate these observations.

1 July 2020 in Annals of Joint
Verified
Journal Article
Open access
PDF file
VKVenu Kavarthapu
Venu Kavarthapu
AVAlexandros Vris
Alexandros Vris
Various deformity reconstruction methods have been described for Charcot midfoot correction. We present our surgical technique using specific principles that involve the choice of surgical approaches, osteotomy and fixation construct based on the patterns of midfoot deformities. We identified three major Charcot midfoot deformity patterns: (I) rocker bottom and forefoot abduction; (II) dorsal subluxation/dislocation; and (III) forefoot adduction. In our experience, specific surgical principles need to be applied for each deformity pattern in order to achieve optimal deformity correction, adequate fixation and reliable bone fusion.

1 July 2020 in Annals of Joint
Verified
Journal Article
Open access
PDF file
IKIngvild Kummen
Ingvild Kummen
NPNgwe Phyo
Ngwe Phyo
VKVenu Kavarthapu
Venu Kavarthapu
Background: Surgical reconstruction of severe Charcot foot deformities using internal fixation technique carries a high risk of major hardware failure. Our aim of this study was to look at the demographics of hardware failure, and the radiological and clinical outcomes in this group. Methods: We studied 78 patients that have undergone Charcot foot reconstruction. The patients’ demographics, radiological and clinical outcomes were recorded within a follow-up period of minimum of 12 months with a mean duration of 31.8 months (12–91 months). Results: Nineteen patients had hardware failure. Only 7/19 of these patients developed full bone fusion radiologically, compared to 49/59 of the non-hardware failure group (P<0.001). Patients with a body mass index (BMI) of greater than 30 kg/m2 are at higher risk of hardware failure (P=0.038). Hindfoot and midfoot combination carries 12 times the risk of metal breakage compared to single segment reconstruction alone (P<0.001). In the hardware-failure group 9/19 were able to weight-bear in shoes, in comparison to 43/59 in the non-hardware failure patients (P=0.040). Limb salvage was achieved in all patients. Conclusions: Hardware failure is common following Charcot deformity corrections. However, the clinical and radiological outcomes are still satisfactory in this group. Further developments of the internal fixation devices may reduce the risk of hardware failure.